Skip to main content

Advertisement

Log in

Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form

  • Matters Arising
  • Published:

From Nature Immunology

View current issue Submit your manuscript

The Original Article was published on 13 February 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Modification of the association between an Nlrp3 activating genetic variant and cardiovascular mortality by triglycerides and ApoC3.

References

  1. Zewinger, S. et al. Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat. Immunol. 21, 30–41 (2020).

    Article  CAS  PubMed  Google Scholar 

  2. Hsu, C.-C. et al. Apolipoprotein C3 induces inflammasome activation only in its delipidated form. Nat. Immunol. https://doi.org/10.1038/s41590-023-01424-1 (2023).

  3. Zheng, C., Khoo, C., Furtado, J. & Sacks, F. M. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation 121, 1722–1734 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mehta, A. & Shapiro, M. D. Apolipoproteins in vascular biology and atherosclerotic disease. Nat. Rev. Cardiol. 19, 168–179 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. Tam, S. P., Dory, L. & Rubinstein, D. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro. J. Lipid Res. 22, 641–651 (1981).

    Article  CAS  PubMed  Google Scholar 

  6. Schunk, S. J. et al. Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. Eur. Heart J. 42, 1742–1756 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

S.Z., W.M., U.L., and T.S. wrote the manuscript. S.Z. and T.S. performed the analyses. J.R., V.J., D.A., E.H., S.T., M.K., S.J.S., D.S., R.K., C.K., E.A., M.W.L., S.R.S., A.P., T.H., S.G., G.S., M.S., U.S., G.A., R.B., G.K., W.J.D., M.D.M., L.R., M.B., J.J., M.K., E.L., B.A.N., and D.F. critically revised the manuscript.

Corresponding author

Correspondence to Thimoteus Speer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zewinger, S., Reiser, J., Jankowski, V. et al. Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form. Nat Immunol 24, 412–413 (2023). https://doi.org/10.1038/s41590-023-01424-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-023-01424-1

  • Springer Nature America, Inc.

This article is cited by

Navigation